This case was reported by a consumer and described the occurrence of pain in arm in a patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (1st dose received on an unknown date and experienced shingles). On an unknown date, the patient received the 1st dose of SHINGRIX. On 28th March 2019, the patient received the 2nd dose of SHINGRIX. On 29th March 2019, not applicable after receiving SHINGRIX and 1 days after receiving SHINGRIX, the patient experienced pain in arm, fever, tiredness, headache, activities of daily living impaired, paresthesia generalized, red rash, erythema, shivering, pain of skin, condition aggravated and generalized rash. On an unknown date, the patient experienced pain in arm, fever, shivering, tiredness, pain of skin, headache, erythema, activities of daily living impaired, generalized rash and red rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, fever, shivering, tiredness, pain of skin, headache, erythema, activities of daily living impaired, generalized rash, red rash, red rash, pain of skin, condition aggravated and generalized rash were unknown and the outcome of the pain in arm, fever, tiredness, headache, activities of daily living impaired and shivering were recovering/resolving and the outcome of the paresthesia generalized was not recovered/not resolved and the outcome of the erythema was recovered/resolved. It was unknown if the reporter considered the pain in arm, fever, shivering, tiredness, pain of skin, headache, erythema, activities of daily living impaired, generalized rash, red rash, pain in arm, fever, tiredness, headache, activities of daily living impaired, red rash, erythema, shivering, pain of skin and generalized rash to be related to SHINGRIX and SHINGRIX. It was unknown if the reporter considered the paresthesia generalized and condition aggravated to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient got shingles after the previous shingles shot that was not supposed to be that effective. However, it was not a severe case and hence it was recommended that they get this SHINGRIX vaccine. The next day after the vaccination, the patient experienced very sore arm, fever, shivering, tiredness, headache, etc. that were listed as side effects, severe enough to limit their normal activity. These symptoms were better on the day of reporting. The patient had a generalized significant paresthesia that hurt to touch. The patient's arm was sorer after the 1st dose of the SHINGRIX and I had some of the side effects mentioned, the second dose seemed to have worse generalized side effects. The patient's skin hurt to touch and just hurt in general, a kind of like when they had shingles, but did not become quite that severe. The patient kept looking for blisters and never saw any but before the day of reporting, they had a generalized red or pink rash that was not defined and the paresthesia was not along dermatomes, but kind of started from their head and over several hours went down patient's whole body from head to torso (front first then back) all the way down their legs. On the day of reporting, the redness seemed to be gone, but the patient still had paresthesia on right lower back, hip, and upper leg. It was patient's 3rd day since getting the shot and they expected it would subside. The patient did not visit the emergency room. The patient did not provide the consent to follow up.